Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinial Trial of New Chemopreventive Agents - Ws#68 - Zileut-261005022
Wayne State University, Detroit, MI, United States
Search grants from Wayne State University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Epigenetic Gene Regulation by JAK1 Kinase in Diffuse Large B-Cell Lymphoma
The Dynamics of Molecular Recognition by Proteins from 2D IR Spectroscopy and MD Simulations
Carolina Population Center
Scientific Evaluation
Presidential Award for Excellence in Science and MathematicsTeaching
Recently added grants:
Targeted depletion of programmed death-1 positive cells, a method that not only stops autoimmune attack but also preserves adaptive immunity
Systems biology, endothelial regulation of fibrosis, and pulmonary vascular disease
PSGL-1 mechanisms of T cell exhaustion
A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC
Wnt-mediated epithelial-endothelial crosstalk in the generation and regeneration of the lung alveolus
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA005022-003
Application #
6828906
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Related projects
NIH 2003
N01 CA
Phase II Clinial Trial of New Chemopreventive Agents - Ws#68 - Zileut-261005022
/ Wayne State University
NIH 2002
N01 CA
Phase II Clinial Trial of New Chemopreventive Agents - Ws#68 - Zileut-261005022
/ Wayne State University
Comments
Be the first to comment on this grant